MYLAN FDA Approval ANDA 211259

ANDA 211259

MYLAN

FDA Drug Application

Application #211259

Application Sponsors

ANDA 211259MYLAN

Marketing Status

Prescription001

Application Products

001SUSPENSION;ORAL2.5MG/ML0CLOBAZAMCLOBAZAM

FDA Submissions

UNKNOWN; ORIG1AP2018-10-22STANDARD
LABELING; LabelingSUPPL2AP2022-02-11STANDARD

Submissions Property Types

ORIG1Null7
SUPPL2Null15

TE Codes

001PrescriptionAB

CDER Filings

MYLAN
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 211259
            [companyName] => MYLAN
            [docInserts] => ["",""]
            [products] => [{"drugName":"CLOBAZAM","activeIngredients":"CLOBAZAM","strength":"2.5MG\/ML","dosageForm":"SUSPENSION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/22\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"07\/19\/2019","submission":"SUPPL-1","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2019-07-19
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.